S 1500 Introduced Re-checks Congress.gov for new actions and updates the bill's status, and fills in any sponsors, committees, or related bills that are missing. It does not re-pull sponsors/cosponsors/committees/related — those rarely change — and it skips all work if nothing has changed upstream, so it's cheap to click.
Access to Breast Cancer Diagnosis Act of 2025
To amend title XXVII of the Public Health Service Act to prohibit group health plans and health insurance issuers offering group or individual health insurance coverage from imposing cost-sharing requirements with respect to diagnostic and supplemental breast examinations.
Summary
- Adds a new section to the Public Health Service Act that bars group health plans and group or individual health insurance issuers from imposing deductibles, coinsurance, copayments, or related out-of-pocket maximums on diagnostic and supplemental breast examinations.
- Defines a diagnostic breast examination as a medically necessary exam, such as diagnostic mammography, breast MRI, or breast ultrasound, used to evaluate an abnormality seen or suspected on a screening or detected by another means.
- Defines a supplemental breast examination as a medically necessary screening exam, such as breast MRI or breast ultrasound, used when no abnormality is seen or suspected and furnished based on personal or family history or other risk factors.
- Allows plans and insurers to still require timely prior authorization or other appropriate utilization controls, and does not override state laws that give greater protection for these examinations.
- Applies the same no-cost-sharing rule to grandfathered health plans and treats a high-deductible health plan as still qualifying for health savings account eligibility when it has no deductible for these examinations.
- Takes effect for plan years beginning on or after January 1, 2026.
AI-generated plain-language summary of the bill text — neutral, and may be imperfect. See the full text below for the exact wording.
Sponsor (1)
-
Sen. Shaheen, Jeanne (D-NH)
10 cosponsors
-
Sen. Britt, Katie Boyd (R-AL) -
Sen. Capito, Shelley Moore (R-WV) -
Sen. Fetterman, John (D-PA) -
Sen. Gillibrand, Kirsten E. (D-NY) -
Sen. Kelly, Mark (D-AZ) -
Sen. Ossoff, Jon (D-GA) -
Sen. Schiff, Adam B. (D-CA) -
Sen. Warnock, Raphael G. (D-GA) -
Sen. Whitehouse, Sheldon (D-RI) -
Sen. Wicker, Roger F. (R-MS)
Money behind the sponsor
Top reported contributors to Jeanne Shaheen’s campaign committee (2024 cycle) — who funds the bill’s sponsor, not a claim about this bill. Data from FEC.
- THEGROUP $16,200
- BLINK TECH INC. $13,200
- PARKER MEGGITT $7,725
- INSIGHT $7,600
- FAROS PROPERTIES $6,600
Organizations whose employees gave the most — itemized individual contributions grouped by the donor’s reported employer (FEC Schedule A). Full finance for Jeanne Shaheen → · Outside spending →
Actions (2)
- Apr 28, 2025 Read twice and referred to the Committee on Health, Education, Labor, and Pensions. · senate
- Apr 28, 2025 Introduced in Senate
Full text
IN THE SENATE OF THE UNITED STATES
April 28, 2025
Mrs. Shaheen (for herself, Mrs. Britt, and Mrs. Capito) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions
A BILL
To amend title XXVII of the Public Health Service Act to prohibit group health plans and health insurance issuers offering group or individual health insurance coverage from imposing cost-sharing requirements with respect to diagnostic and supplemental breast examinations.
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the “Access to Breast Cancer Diagnosis Act of 2025”.
SEC. 2. REQUIRING DIAGNOSTIC AND SUPPLEMENTAL BREAST EXAMINATIONS TO BE COVERED WITH NO COST-SHARING REQUIREMENTS.
(a) In General.—Subpart II of part A of title XXVII of the Public Health Service Act (42 U.S.C. 300gg-11 et seq.) is amended by adding at the end the following new section:
“SEC. 2730. DIAGNOSTIC AND SUPPLEMENTAL BREAST EXAMINATIONS.
“(a) In General.—In the case of a group health plan, or a health insurance issuer offering group or individual health insurance coverage, that provides benefits with respect to diagnostic and supplemental breast examinations furnished to an individual enrolled under such plan or such coverage, such plan or coverage shall not impose any cost-sharing requirements for these benefits.
“(b) Construction.—Nothing in this section shall be construed—
“(1) to prohibit a group health plan or health insurance issuer from requiring timely prior authorization or imposing other appropriate utilization controls in approving coverage for any diagnostic and supplemental breast examination; or
“(2) to supersede a State law that provides greater protections with respect to the coverage of diagnostic and supplemental breast examinations than is provided under this section.
“(c) Definitions.—In this section:
“(1) Cost-sharing requirements.—The term ‘cost-sharing requirements’ means a deductible, coinsurance, copayment, and any maximum limitation on the application of such a deductible, coinsurance, copayment or similar out-of-pocket expense.
“(2) Diagnostic breast examination.—The term ‘diagnostic breast examination’ means a medically necessary and appropriate (in accordance with National Comprehensive Cancer Network Guidelines) examination of the breast (including, but not limited to such an examination using diagnostic mammography, breast magnetic resonance imaging, or breast ultrasound) that is—
“(A) used to evaluate an abnormality seen or suspected from a screening examination for breast cancer; or
“(B) used to evaluate an abnormality detected by another means of examination.
“(3) Supplemental breast examinations.—The term ‘supplemental breast examination’ means a medically necessary and appropriate (in accordance with National Comprehensive Cancer Network Guidelines) examination of the breast (including, but not limited to such an examination using breast magnetic resonance imaging or breast ultrasound) that is—
“(A) used to screen for breast cancer when there is no abnormality seen or suspected; and
“(B) furnished based on personal or family medical history or additional factors that may increase the individual’s risk of breast cancer.”.
(b) Application to Grandfathered Health Plans.—Section 1251(a)(4)(A) of the Patient Protection and Affordable Care Act (42 U.S.C. 18011(a)(4)(A)) is amended—
(1) by striking “title” and inserting “title, or as added after the date of the enactment of this Act”; and
(2) by adding at the end the following new clause:
“(v) Section 2730 (relating to coverage for diagnostic and supplemental breast examinations).”.
(c) Application to High Deductible Health Plans With Health Savings Account Eligibility.—Section 223(c)(2) of the Internal Revenue Code of 1986 is amended by adding at the end the following:
“(H) Safe harbor for absence of deductible for diagnostic and supplemental breast examinations.—In the case of plan years beginning on or after January 1, 2026, a plan shall not fail to be treated as a high deductible health plan by reason of failing to have a deductible for diagnostic and supplemental breast examinations.”.
(d) Effective Date.—The amendments made by this section shall apply with respect to plan years beginning on or after January 1, 2026. <all>
Text versions (1)
Bills are re-published as they move (Introduced → Reported → Engrossed → Enrolled …). Each stage below is a separate text; pick two to see what changed. Data from Congress.gov.
Similar bills (6)
Bills with similar text or summary — includes reintroductions across Congresses. Ranked by semantic similarity of the bill text (computed locally); a neutral discovery aid, not a claim the bills are duplicates.
Comments